| Tag | Content |
|---|
EnhancerAtlas ID | HS154-11731 |
Organism | Homo sapiens |
Tissue/cell | Osteoblast |
Coordinate | chr19:52288400-52289180 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| LMX1B | MA0703.2 | chr19:52289078-52289089 | ATTTTAATTAA | + | 6.62 | | NFAT5 | MA0606.1 | chr19:52289071-52289081 | ATTTTCCATT | + | 6.02 | | NFATC1 | MA0624.1 | chr19:52289071-52289081 | ATTTTCCATT | + | 6.02 | | NFATC3 | MA0625.1 | chr19:52289071-52289081 | ATTTTCCATT | + | 6.02 | | ZNF263 | MA0528.1 | chr19:52288976-52288997 | GGAGAATGAAGAGCAGGGGAA | + | 6.13 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_40343 | chr19:52288442-52288959 | K562 | | SE_56354 | chr19:52285817-52289528 | u87 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH19I051784 | chr19 | 52287318 | 52291162 |
|
Enhancer Sequence | GGCTCCCCGG CTTCCCCCCA CCCACCAAGT TCTTCTTCAA AACTCTGCTC TCTGAATGGT 60
TGGGGAGGCT GATTTGAGTA ATAATGAAAC TCCAGTCTCC TGCATAGCTG GCTCTGCGTG 120
ACTTACTCTT TCTCTGTTGC AATTTCCCCG CCTTGATAAA TTGACTCTGT CTAGGCAGCC 180
GGCAAGGTGA ACCCATTGGG TGGTTACACT TCACATTAGC AGTTCATGTA ATTCTGATTT 240
CAGCTCACAT GTCACCTCCT CAAGATATTG TTTTCTGAGC CTCTAAGATA AAGTAGCCTC 300
TCAGTCACTC TCCATTCTAG TCCATGAAAC TGTACTTATT CTCTTGATAA CCTTCATTGC 360
TGCCTTCTGT CAATCACAAA ATTACCCTTT TCCCTCAATC TTTACAATCA CTGATCTGAG 420
TGCCTTTGCA TTTCTCACTC TCTGTCTCTT CATCTATTGA AACAGCCTCT GCATTCACCT 480
GCTATTCTGT GAAAGGGGAG TAGATTTCCA CCGAATGATG TCTGCGCCAG TTCTGGTAGA 540
GCTTGGTAAG CATGAGTTAG AAATTTGGAA ACCACTGGAG AATGAAGAGC AGGGGAATGT 600
CATGATTTGC TATGTTTTTA AAATTTTTAT ATTGACTCTG AAGCCGAATA GCAACTTTCA 660
AAAGAGTAAA TATTTTCCAT TTTAATTAAG TCCAATTTAT ACTTTTTTCT TCTATGGATT 720
GTGCTTTTGG TGTCGTGTCT ATGAACTCCC TGCTTAGCCT TAAGTCTTCA CTATTTCTTC 780
|
